SouthernWorldwide.com – The Supreme Court has decided to maintain broader access to the abortion pill mifepristone, issuing an administrative stay that blocks a lower court’s ruling. This decision ensures that telehealth prescribing and mail delivery of the medication can continue while the legal challenges surrounding it are ongoing.
The Supreme Court’s order, issued on a Thursday, effectively preserves the current Food and Drug Administration (FDA) regulations. These regulations permit patients to obtain mifepristone without requiring an in-person consultation with a doctor.
This move was not unanimous, as Justice Clarence Thomas dissented from the court’s decision. Justice Samuel Alito also filed a separate dissenting opinion.
Read more : Bob Pockrass' Indy 500 Qualifying Picks for FOX Super 6
The legal dispute originated from challenges to the FDA’s modifications made in 2023. These changes expanded the accessibility of mifepristone, notably by allowing it to be prescribed via telehealth and delivered through the mail.
Previously, a ruling from the Fifth Circuit Court of Appeals had sought to reinstate earlier requirements for in-person dispensing of the medication. The Supreme Court’s current action temporarily halts these restrictions imposed by the Louisiana-based court, allowing the legal process to continue without immediate changes to access.
This is a developing story, and further updates will be provided as more information becomes available.
